{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:39:29Z","timestamp":1791661169352,"version":"4.3.4"},"reference-count":137,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The pharmacological treatment of epilepsy is purely symptomatic. Despite many decades of intensive research, causal treatment of this common neurologic disorder is still unavailable. Nevertheless, it is expected that advances in modern neuroscience and molecular biology tools, as well as improved animal models may accelerate designing antiepileptogenic and epilepsy-modifying drugs. Epileptogenesis triggers a vast array of genomic, epigenomic and transcriptomic changes, which ultimately lead to morphological and functional transformation of specific neuronal circuits resulting in the occurrence of spontaneous convulsive or nonconvulsive seizures. Recent decades unraveled molecular processes and biochemical signaling pathways involved in the proepileptic transformation of brain circuits including oxidative stress, apoptosis, neuroinflammatory and neurotrophic factors. The \u201comics\u201d data derived from both human and animal epileptic tissues, as well as electrophysiological, imaging and neurochemical analysis identified a plethora of possible molecular targets for drugs, which could interfere with various stages of epileptogenetic cascade, including inflammatory processes and neuroplastic changes. In this narrative review, we briefly present contemporary views on the neurobiological background of epileptogenesis and discuss the advantages and disadvantages of some more promising molecular targets for antiepileptogenic pharmacotherapy.<\/jats:p>","DOI":"10.3390\/ijms24032928","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T02:35:10Z","timestamp":1675391710000},"page":"2928","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Emerging Molecular Targets for Anti-Epileptogenic and Epilepsy Modifying Drugs"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1582-0920","authenticated-orcid":false,"given":"Katarzyna","family":"\u0141ukasiuk","sequence":"first","affiliation":[{"name":"The Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur St., 02-093 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9640-2159","authenticated-orcid":false,"given":"W\u0142adys\u0142aw","family":"Laso\u0144","sequence":"additional","affiliation":[{"name":"Maj Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna 12, 31-343 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/bcp.15139","article-title":"Novel treatments in epilepsy guided by genetic diagnosis","volume":"88","author":"Marini","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2019.03.001","article-title":"Identifying mutations in epilepsy genes: Impact on treatment selection","volume":"152","author":"Perucca","year":"2019","journal-title":"Epilepsy Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3389\/fnins.2019.01135","article-title":"Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy with or Without Neurodevelopmental Delay in 246 Pediatric Patients","volume":"13","author":"Roca","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"118826","DOI":"10.1016\/j.lfs.2020.118826","article-title":"Revisiting the role of neurotransmitters in epilepsy: An updated review","volume":"265","author":"Akyuz","year":"2021","journal-title":"Life Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"107966","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hung, T.-Y., Wu, S.-N., and Huang, C.-W. (2021). The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability. Biomedicines, 9.","DOI":"10.3390\/biomedicines9040369"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wu, P.-M., Lai, P.-C., Cho, H.-Y., Chuang, T.-H., Wu, S.-N., and Tu, Y.-F. (2022). Effective Perturbations by Phenobarbital on INa, IK(erg), IK(M) and IK(DR) during Pulse Train Stimulation in Neuroblastoma Neuro-2a Cells. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081968"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lai, M.-C., Wu, S.-N., and Huang, C.-W. (2022). Rufinamide, a Triazole-Derived Antiepileptic Drug, Stimulates Ca2+-Activated K+ Currents While Inhibiting Voltage-Gated Na+ Currents. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213677"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wu, P.-M., Cho, H.-Y., Chiang, C.-W., Chuang, T.-H., Wu, S.-N., and Tu, Y.-F. (2022). Characterization in Inhibitory Effectiveness of Carbamazepine in Voltage-Gated Na+ and Erg-Mediated K+ Currents in a Mouse Neural Crest-Derived (Neuro-2a) Cell Line. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147892"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open"},{"key":"ref_12","first-page":"17","article-title":"Drug-Resistant Epilepsy and Surgery","volume":"16","author":"Sheng","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options","volume":"72","author":"Potschka","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.seizure.2010.10.027","article-title":"Antiepileptic drug therapy the story so far","volume":"19","author":"Brodie","year":"2010","journal-title":"Seizure"},{"key":"ref_15","first-page":"45","article-title":"Recent advances related to basic mechanisms of epileptogenesis","volume":"11","author":"Lowenstein","year":"1996","journal-title":"Epilepsy Res. Suppl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2009.02113.x","article-title":"The impact of genetics on the classification of epilepsy syndromes","volume":"50","author":"Zara","year":"2009","journal-title":"Epilepsia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.pediatrneurol.2014.08.019","article-title":"Prevention of Epileptogenesis\u2014A new goal for epilepsy therapy","volume":"51","author":"Kotulska","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(15)00248-3","article-title":"Development of epilepsy after ischaemic stroke","volume":"15","author":"Roivainen","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yebeh.2008.09.023","article-title":"Molecular and cellular basis of epileptogenesis in symptomatic epilepsy","volume":"14","author":"Lukasiuk","year":"2009","journal-title":"Epilepsy Behav."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","article-title":"Mechanisms of epileptogenesis and potential treatment targets","volume":"10","author":"Lukasiuk","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Manna, I., Fortunato, F., De Benedittis, S., Sammarra, I., Bertoli, G., Labate, A., and Gambardella, A. (2022). Non-Coding RNAs: New Biomarkers and Therapeutic Targets for Temporal Lobe Epilepsy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063063"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"107605","DOI":"10.1016\/j.neuropharm.2019.04.011","article-title":"The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments","volume":"167","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuropharm.2015.03.014","article-title":"The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy","volume":"95","author":"Twele","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s13311-022-01299-4","article-title":"Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development","volume":"19","author":"Guarino","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1523\/JNEUROSCI.2939-18.2019","article-title":"TrkB-Shc Signaling Protects against Hippocampal Injury Following Status Epilepticus","volume":"39","author":"Huang","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1073858405278266","article-title":"To BDNF or Not to BDNF: That is the Epileptic Hippocampus","volume":"11","author":"Koyama","year":"2005","journal-title":"Neuroscientist"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"107734","DOI":"10.1016\/j.neuropharm.2019.107734","article-title":"Targeting BDNF\/TrkB pathways for preventing or suppressing epilepsy","volume":"167","author":"Lin","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41467-021-21649-8","article-title":"A critical period of neuronal activity results in aberrant neurogenesis rewiring hippocampal circuitry in a mouse model of epilepsy","volume":"12","author":"Lybrand","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1523\/JNEUROSCI.1574-14.2015","article-title":"Reactive Astrogliosis Causes the Development of Spontaneous Seizures","volume":"35","author":"Robel","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.expneurol.2012.02.002","article-title":"Decreased expression of the glial water channel aquaporin-4 in the intrahippocampal kainic acid model of epileptogenesis","volume":"235","author":"Lee","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/glia.22300","article-title":"Epilepsy: Crucial role for astrocytes","volume":"60","author":"Boison","year":"2012","journal-title":"Glia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pneurobio.2007.12.002","article-title":"The adenosine kinase hypothesis of epileptogenesis","volume":"84","author":"Boison","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/epi.14580","article-title":"No latency to dentate granule cell epileptogenesis in experimental temporal lobe epilepsy with hippocampal sclerosis","volume":"59","author":"Bumanglag","year":"2018","journal-title":"Epilepsia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2012.01.022","article-title":"Defining \u201cepileptogenesis\u201d and identifying \u201cantiepileptogenic targets\u201d in animal models of acquired temporal lobe epilepsy is not as simple as it might seem","volume":"69","author":"Sloviter","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40263-014-0223-x","article-title":"mTOR Inhibition in Epilepsy: Rationale and Clinical Perspectives","volume":"29","author":"Ostendorf","year":"2015","journal-title":"CNS Drugs"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"106282","DOI":"10.1016\/j.eplepsyres.2020.106282","article-title":"Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy","volume":"161","author":"Hodges","year":"2020","journal-title":"Epilepsy Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1523\/JNEUROSCI.2754-19.2020","article-title":"Microglial mTOR is neuronal protective and anti-epileptogenic in the pilocarpine model of temporal lobe epilepsy","volume":"40","author":"Zhao","year":"2020","journal-title":"J. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.phrs.2016.03.039","article-title":"mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis","volume":"107","author":"Citraro","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.22311","article-title":"Blood-brain barrier dysfunction, TGF\u03b2 signaling, and astrocyte dysfunction in epilepsy","volume":"60","author":"Heinemann","year":"2012","journal-title":"Glia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"107742","DOI":"10.1016\/j.neuropharm.2019.107742","article-title":"Inflammation and reactive oxygen species as disease modifiers in epilepsy","volume":"167","author":"Terrone","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2213162119","DOI":"10.1073\/pnas.2213162119","article-title":"Inhibition of connexin hemichannels alleviates neuroinflammation and hyperexcitability in temporal lobe epilepsy","volume":"119","author":"Guo","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2014.12.021","article-title":"Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"287","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1083\/jcb.200708213","article-title":"Important role of matrix metalloproteinase 9 in epileptogenesis","volume":"180","author":"Wilczynski","year":"2008","journal-title":"J. Cell Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pharmthera.2011.12.008","article-title":"Integrins as receptor targets for neurological disorders","volume":"134","author":"Wu","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/epi.16595","article-title":"Drebrin expression patterns in patients with refractory temporal lobe epilepsy and hippocampal sclerosis","volume":"61","author":"Dombroski","year":"2020","journal-title":"Epilepsia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.expneurol.2005.08.007","article-title":"Mossy fibers are the primary source of afferent input to ectopic granule cells that are born after pilocarpine-induced seizures","volume":"196","author":"Pierce","year":"2005","journal-title":"Exp. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.2879352","article-title":"Decreased Hippocampal Inhibition and a Selective Loss of Interneurons in Experimental Epilepsy","volume":"235","author":"Sloviter","year":"1987","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1523\/JNEUROSCI.5191-03.2004","article-title":"Rapid Deletion of Mossy Cells Does Not Result in a Hyperexcitable Dentate Gyrus: Implications for Epileptogenesis","volume":"24","author":"Ratzliff","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"14291","DOI":"10.1523\/JNEUROSCI.1148-11.2011","article-title":"Rapid Loss of Dendritic HCN Channel Expression in Hippocampal Pyramidal Neurons following Status Epilepticus","volume":"31","author":"Jung","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kazmierska-Grebowska, P., Siwiec, M., Sowa, J.E., Caban, B., Kowalczyk, T., Bocian, R., and MacIver, M.B. (2021). Lamotrigine Attenuates Neuronal Excitability, Depresses GABA Synaptic Inhibition, and Modulates Theta Rhythms in Rat Hippocampus. Int. J. Mol. Sci., 22.","DOI":"10.20944\/preprints202111.0067.v2"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"106484","DOI":"10.1016\/j.eplepsyres.2020.106484","article-title":"Testing broad-spectrum and isoform-preferring HCN channel blockers for anticonvulsant properties in mice","volume":"168","author":"Kharouf","year":"2020","journal-title":"Epilepsy Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nurt.2009.01.019","article-title":"Alteration of epileptogenesis genes","volume":"6","author":"Raol","year":"2009","journal-title":"Neurotherapeutics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.neuroscience.2005.08.008","article-title":"The seizure-related phenotype of brain-derived neurotrophic factor knockdown mice","volume":"136","author":"Barton","year":"2005","journal-title":"Neuroscience"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1111\/j.0953-816X.2004.03440.x","article-title":"Brain-derived neurotrophic factor signaling modifies hip-pocampal gene expression during epileptogenesis in transgenic mice","volume":"19","author":"Lahteinen","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1460-9568.2002.01897.x","article-title":"Decreased BDNF signalling in transgenic mice reduces epileptogenesis","volume":"15","author":"Saarelainen","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0306-4522(00)00351-1","article-title":"Brain-derived neurotrophic factor delays hippocampal kindling in the rat","volume":"100","author":"Reibel","year":"2000","journal-title":"Neuroscience"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-4886(03)00086-4","article-title":"Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model","volume":"182","author":"Borges","year":"2003","journal-title":"Exp. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/glia.22313","article-title":"Astrocyte dysfunction in temporal lobe epilepsy: K+ channels and gap junction coupling","volume":"60","author":"Seifert","year":"2012","journal-title":"Glia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2011.08.024","article-title":"Neuron\u2013astrocyte signaling and epilepsy","volume":"244","author":"Seifert","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/brain\/awn133","article-title":"Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats","volume":"131","author":"Eid","year":"2008","journal-title":"Brain"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/glia.22318","article-title":"Astrocyte calcium signaling and epilepsy","volume":"60","author":"Carmignoto","year":"2012","journal-title":"Glia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7007-10-26","article-title":"Astrocytes convert network excitation to tonic inhibition of neurons","volume":"10","author":"Nyitrai","year":"2012","journal-title":"BMC Biol."},{"key":"ref_65","first-page":"583","article-title":"Contribution of astrocytes to seizure activity","volume":"79","author":"Heinemann","year":"1999","journal-title":"Adv. Neurol."},{"key":"ref_66","first-page":"695","article-title":"Role of glial cation and anion transport mechanisms in etiology and arrest of seizures","volume":"44","author":"White","year":"1986","journal-title":"Adv. Neurol."},{"key":"ref_67","first-page":"571","article-title":"Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice","volume":"118","author":"Li","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-1-0716-2384-8_21","article-title":"Analyzing the Role of the P2X7 Receptor in Epilepsy","volume":"2510","author":"Alves","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1523\/JNEUROSCI.4009-15.2016","article-title":"Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy","volume":"36","author":"Artalejo","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jpeds.2013.12.053","article-title":"Mammalian Target of Rapamycin Inhibitors for Intractable Epilepsy and Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex","volume":"164","author":"Cardamone","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Rajan, I., Savelieva, K.V., Ye, G.-L., Wang, C.-Y., Malbari, M.M., Friddle, C., Lanthorn, T.H., and Zhang, W. (2009). Loss of the Putative Catalytic Domain of HDAC4 Leads to Reduced Thermal Nociception and Seizures while Allowing Normal Bone Development. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006612"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1523\/JNEUROSCI.22-19-08422.2002","article-title":"Altered Histone Acetylation at Glutamate Receptor 2 and Brain-Derived Neurotrophic Factor Genes is an Early Event Triggered by Status Epilepticus","volume":"22","author":"Huang","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1242\/jcs.00804","article-title":"Chromatin remodeling and neuronal response: Multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons","volume":"116","author":"Crosio","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1460-9568.2006.04641.x","article-title":"Histone modifications in kainate-induced status epilepticus","volume":"23","author":"Sng","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1523\/JNEUROSCI.0589-04.2004","article-title":"Histone Modifications at Gene Promoter Regions in Rat Hippocampus after Acute and Chronic Electroconvulsive Seizures","volume":"24","author":"Tsankova","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1523\/JNEUROSCI.0110-07.2007","article-title":"Epigenetic Modulation of Seizure-Induced Neurogenesis and Cognitive Decline","volume":"27","author":"Jessberger","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuropharm.2006.05.021","article-title":"Treatment with valproate after status epilepticus: Effect on neuronal damage, epileptogenesis, and behavioral alterations in rats","volume":"51","author":"Brandt","year":"2006","journal-title":"Neuropharmacology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s12031-020-01780-9","article-title":"Differential DNA Methylation Profiles in Patients with Temporal Lobe Epilepsy and Hippocampal Sclerosis ILAE Type I","volume":"71","author":"Zhang","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"25668","DOI":"10.1038\/srep25668","article-title":"Etiology matters\u2014Genomic DNA Methylation Patterns in Three Rat Models of Acquired Epilepsy","volume":"6","author":"Pitkanen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"931356","DOI":"10.3389\/fncel.2022.931356","article-title":"The potential role of DNA methylation as preventive treatment target of epileptogenesis","volume":"16","author":"Berger","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Berger, T.C., Vigeland, M.D., Hjorthaug, H.S., Etholm, L., Nome, C.G., Taub\u00f8ll, E., Heuser, K., and Selmer, K.K. (2019). Neuronal and glial DNA methylation and gene expression changes in early epileptogenesis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0226575"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1523\/JNEUROSCI.2766-06.2006","article-title":"Potential new antiepi-leptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy","volume":"26","author":"Gorter","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1460-9568.2003.02461.x","article-title":"cDNA profiling of epileptogenesis in the rat brain","volume":"17","author":"Lukasiuk","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1007\/s11033-022-07188-5","article-title":"Aberrant expression of miRNAs in epilepsy","volume":"49","author":"Hussen","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2017.01.017","article-title":"microRNAs in the pathophysiology of epilepsy","volume":"667","author":"Brennan","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Bot, A.M., D\u0119bski, K.J., and Lukasiuk, K. (2013). Alterations in miRNA Levels in the Dentate Gyrus in Epileptic Rats. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076051"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Puhakka, N., Bot, A.M., Vuokila, N., Debski, K.J., Lukasiuk, K., and Pitk\u00e4nen, A. (2017). Chronically dysregulated NOTCH1 interactome in the dentate gyrus after traumatic brain injury. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172521"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/epi.13870","article-title":"MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus","volume":"58","author":"Bencurova","year":"2017","journal-title":"Epilepsia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2013.10.026","article-title":"Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy","volume":"62","author":"Gorter","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"11592","DOI":"10.1038\/s41598-017-11510-8","article-title":"Systematic review and meta-analysis of differentially expressed miRNAs in experimental and human temporal lobe epilepsy","volume":"7","author":"Korotkov","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"101749","DOI":"10.1016\/j.arr.2022.101749","article-title":"Role of lncRNAs and circRNAs in epilepsy","volume":"82","author":"Hussen","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1159\/000487161","article-title":"High-Throughput Data of Circular RNA Profiles in Human Temporal Cortex Tissue Reveals Novel Insights into Temporal Lobe Epilepsy","volume":"45","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbrc.2015.04.149","article-title":"Dysregulation of long non-coding RNAs in mouse models of localization-related epilepsy","volume":"462","author":"Lee","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"564301","DOI":"10.3389\/fgene.2020.564301","article-title":"Identification of Specific Circular RNA Expression Patterns and MicroRNA Interaction Networks in Mesial Temporal Lobe Epilepsy","volume":"11","author":"Gray","year":"2020","journal-title":"Front. Genet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8511066","DOI":"10.1155\/2022\/8511066","article-title":"Proteomic Analysis Reveals the Vital Role of Synaptic Plasticity in the Pathogenesis of Temporal Lobe Epilepsy","volume":"2022","author":"Qian","year":"2022","journal-title":"Neural Plast."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"106412","DOI":"10.1016\/j.eplepsyres.2020.106412","article-title":"Proteomic profiling of sclerotic hippocampus revealed dysregulated packaging of vesicular neurotransmitters in temporal lobe epilepsy","volume":"166","author":"Zhang","year":"2020","journal-title":"Epilepsy Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"106502","DOI":"10.1016\/j.eplepsyres.2020.106502","article-title":"Proteomic profile differentiating between mesial temporal lobe epilepsy with and without hippocampal sclerosis","volume":"168","author":"Furukawa","year":"2020","journal-title":"Epilepsy Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"fcab021","DOI":"10.1093\/braincomms\/fcab021","article-title":"Proteomic differences in the hippocampus and cortex of epilepsy brain tissue","volume":"3","author":"Pires","year":"2021","journal-title":"Brain Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hipo.23268","article-title":"Multi-omics analysis suggests enhanced epileptogenesis in the Cornu Ammonis 3 of the pilocarpine model of mesial temporal lobe epilepsy","volume":"31","author":"Canto","year":"2021","journal-title":"Hippocampus"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acn3.51533","article-title":"Benchmarking the proteomic profile of animal models of mesial temporal epilepsy","volume":"9","author":"Canto","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment Outcomes in Patients with Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2008.02005.x","article-title":"Preventing and treating posttraumatic seizures: The human experience","volume":"50","author":"Temkin","year":"2009","journal-title":"Epilepsia"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s13311-014-0266-1","article-title":"The Potential of Antiseizure Drugs and Agents that Act on Novel Molecular Targets as Antiepileptogenic Treatments","volume":"11","author":"Kaminski","year":"2014","journal-title":"Neurotherapeutics"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1528-1167.2005.35204.x","article-title":"Separation of Antiepileptogenic and Antiseizure Effects of Levetiracetam in the Spontaneously Epileptic Rat (SER)","volume":"46","author":"Yan","year":"2005","journal-title":"Epilepsia"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1528-1167.2007.01458.x","article-title":"Early treatment suppresses the development of spike-wave epilepsy in a rat model","volume":"49","author":"Blumenfeld","year":"2007","journal-title":"Epilepsia"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.121.000585","article-title":"Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat","volume":"379","author":"Eastman","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Miziak, B., Konarzewska, A., U\u0142amek-Kozio\u0142, M., Dudra-Jastrz\u0119bska, M., Pluta, R., and Czuczwar, S.J. (2020). Anti-Epileptogenic Effects of Antiepileptic Drugs. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072340"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"730257","DOI":"10.3389\/fphar.2021.730257","article-title":"Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy","volume":"12","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_109","first-page":"94","article-title":"Fk506 Aggravates Development and Severity of Disease in the Rat Model of Temporal Lobe Epilepsy","volume":"50","author":"Lukasiuk","year":"2009","journal-title":"Epilepsia"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3345\/kjp.2011.54.6.241","article-title":"Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis","volume":"54","author":"Kim","year":"2011","journal-title":"Korean J. Pediatr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbrc.2012.02.143","article-title":"Rapamycin suppresses the recurrent excitatory circuits of dentate gyrus in a mouse model of temporal lobe epilepsy","volume":"420","author":"Tang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cne.23681","article-title":"Blockade of excitatory synaptogenesis with proximal dendrites of dentate granule cells following rapamycin treatment in a mouse model of temporal lobe epilepsy","volume":"523","author":"Yamawaki","year":"2014","journal-title":"J. Comp. Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2011.12.051","article-title":"Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy","volume":"509","author":"Sliwa","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1523\/JNEUROSCI.4179-08.2009","article-title":"Inhibition of the Mammalian Target of Rapamycin Signaling Pathway Suppresses Dentate Granule Cell Axon Sprouting in a Rodent Model of Temporal Lobe Epilepsy","volume":"29","author":"Buckmaster","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1523\/JNEUROSCI.4852-10.2011","article-title":"Rapamycin Suppresses Mossy Fiber Sprouting but Not Seizure Frequency in a Mouse Model of Temporal Lobe Epilepsy","volume":"31","author":"Buckmaster","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/epi.16955","article-title":"Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital","volume":"62","author":"Knox","year":"2021","journal-title":"Epilepsia"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2006.02.016","article-title":"Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"23","author":"Jung","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.expneurol.2010.03.014","article-title":"The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy","volume":"224","author":"Polascheck","year":"2010","journal-title":"Exp. Neurol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2008.12.006","article-title":"Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy","volume":"84","author":"Holtman","year":"2009","journal-title":"Epilepsy Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte-endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nat. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2015.12.002","article-title":"Minocycline fails to exert antiepileptogenic effects in a rat status epilepticus model","volume":"771","author":"Russmann","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eplepsyres.2004.07.005","article-title":"Atipamezole, an alpha (2)-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats","volume":"61","author":"Narkilahti","year":"2004","journal-title":"Epilepsy Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eplepsyres.2009.02.019","article-title":"Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model","volume":"85","author":"Echegoyen","year":"2009","journal-title":"Epilepsy Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"107962","DOI":"10.1016\/j.yebeh.2021.107962","article-title":"Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy","volume":"119","author":"Leite","year":"2021","journal-title":"Epilepsy Behav."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/epi.17303","article-title":"Statins as antiepileptogenic drugs: Analyzing the evidence and identifying the most promising statin","volume":"63","author":"Hufthy","year":"2022","journal-title":"Epilepsia"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"107400","DOI":"10.1016\/j.yebeh.2020.107400","article-title":"Statins in primary prevention of poststroke seizures and epilepsy: A systematic review","volume":"112","author":"Nucera","year":"2020","journal-title":"Epilepsy Behav."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ana.24147","article-title":"Losartan prevents acquired epilepsy via TGF-\u03b2 signaling suppression","volume":"75","author":"Cacheaux","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pbb.2014.10.005","article-title":"Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy","volume":"127","author":"Tchekalarova","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"608001","DOI":"10.3389\/fnmol.2020.608001","article-title":"NPY and Gene Therapy for Epilepsy: How, When,... and Y","volume":"13","author":"Cattaneo","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"868531","DOI":"10.3389\/fnmol.2022.868531","article-title":"Gene and Cell Therapy for Epilepsy: A Mini Review","volume":"15","author":"Shaimardanova","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.abq6656","article-title":"On-demand cell-autonomous gene therapy for brain circuit disorders","volume":"378","author":"Qiu","year":"2022","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"106601","DOI":"10.1016\/j.eplepsyres.2021.106601","article-title":"A comparison of the gut microbiota among adult patients with drug-responsive and drug-resistant epilepsy: An exploratory study","volume":"172","author":"Lee","year":"2021","journal-title":"Epilepsy Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"106742","DOI":"10.1016\/j.eplepsyres.2021.106742","article-title":"Ciprofloxacin for treatment of drug-resistant epilepsy","volume":"176","author":"Cheraghmakani","year":"2021","journal-title":"Epilepsy Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"108860","DOI":"10.1016\/j.yebeh.2022.108860","article-title":"Modification of post-traumatic epilepsy by fecal microbiota transfer","volume":"134","author":"Simpson","year":"2022","journal-title":"Epilepsy Behav."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4291\/wjgp.v13.i5.143","article-title":"Epilepsy and the gut: Perpetrator or victim?","volume":"13","author":"Saeed","year":"2022","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.neuropharm.2015.08.007","article-title":"Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats","volume":"99","author":"Lusardi","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"107934","DOI":"10.1016\/j.pharmthera.2021.107934","article-title":"New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?","volume":"229","author":"Klein","year":"2022","journal-title":"Pharmacol. Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2928\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:22:39Z","timestamp":1760120559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":137,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032928"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032928","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]}}}